Trial Profile
Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Indium 111 DTPA adenosylcobalamin (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- Sponsors Copharos
- 03 Jun 2014 New trial record